Vaxcyte at guggenheim healthcare conference: strong vaccine data, long road
Covered in this story
Analyst targets on Vaxcyte Inc
- BTIG: at $73.8 · target $89 by Oct 2027 · Buy via Investing.com
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $PCVX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Vaxcyte Inc →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.